Dergiler / Güncel Pediatri / 2003 / Cilt: 1 Sayı: 1

İmmun Trombositopenik Purpura Tanı ve Tedavisine Güncel Yaklaşım

Adalet Meral Güneş(Uludağ Üniversitesi Tıp Fakültesi Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Çocuk Hematoloji Bilim Dalı)
Sayfa
73–78
Yayın Tarihi
2003-09-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Çocukluk ça- ğında %80 olguda spontan düzelmesine karşın bazı olgularda ciddi kanamalara yol açabilir

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Idiopatik trombositopenik purpura ITP veya diğer adı ile primer immun trombositopenik purpura trombositlere karşı gelişen otoantikorların trombositleri retiküloendotelyal sistemde parçalaması ile karakterize hematolojik bir hastalıktır.
📊
Temel Bulgular & Veri:Idiopatik trombositopenik purpura ITP veya diğer adı ile primer immun trombositopenik purpura trombositlere karşı gelişen otoantikorların trombositleri retiküloendotelyal sistemde parçalaması ile karakterize hematolojik bir hastalıktır.
💡
Sonuç & Katkı:Çocukluk ça- ğında %80 olguda spontan düzelmesine karşın bazı olgularda ciddi kanamalara yol açabilir
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Idiopatik trombositopenik purpura ITP veya diğer adı ile primer immun trombositopenik purpura trombositlere karşı gelişen otoantikorların trombositleri retiküloendotelyal sistemde parçalaması ile karakterize hematolojik bir hastalıktır. Çocukluk ça- ğında %80 olguda spontan düzelmesine karşın bazı olgularda ciddi kanamalara yol açabilir

🔖

Bu Makaleye Atıf Yap

Güneş, A. M. (2003). İmmun Trombositopenik Purpura Tanı ve Tedavisine Güncel Yaklaşım. Güncel Pediatri, Cilt: 1 Sayı: 1, 73–78. https://ajindex.com/articles/992186

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (46)

  1. George JN, Woolf SH, Raskop GE, et al. Idiopathic Thrombocytopenic Purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3-40.
  2. Lanzkowsky P. Disorders of platelets. In: Lanzkowsky P (ed). Manual of Pediatric Hematology and Oncology 2nd edition. New York, NY: Churchill Livingstone; 1995. p:185- 238.
  3. Pearson HA. The spleen and disturbances of splenic function. In: Nathan DG, Oski FA (eds). Hematology of Infancy and Childhood. Philadelphia PA: Saunders; 1993. p.1058- 70.
  4. Lammi AT, Lovric VA. Idiopathic thrombocytopenic purpura: An epidemiologic study. Pediatrics 1973; 83: 31-6.
  5. Imbach P. Immune thrombocytopenic purpura. In: Lilleyman J, Hann I, Blanchette V (eds). Pediatric Hematology 2nd edition. London: Churchill Livingstone; 2000. p.437 – 53.
  6. George JN, El-Harake MA, Aster RH. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds). Williams Hematology. New York, NY: McGraw-Hill; 1995. p.1315 – 20.
  7. Kurata Y, Miyagawa S, Kosugi S.High titer antinuclear antibodies, anti-SSA/Ro antiboies and antinuclear RNP antbodies in patients with idiopathic thrombocytopenic purpura. Thromb Haemost 1994; 71: 184 – 7.
  8. Stasi S, Stipa E, Masi M. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 1994; 84: 4203.
  9. Lusher JM, Zuelzer WW. Idiopathic thrombocytopenic purpura in childhood. J Pediatr 1966; 68: 971-9.
  10. den Ottolander GJ, Gratama JW, deKoning J, Brand A. Long term follow-up study of 168 patients with immune thrombocytopenia. Scand J haematol 1984; 32: 101-10.
  11. Komrower GM, Watson GH. Prognosis in idiopathic thrombocytopenic purpura of chidhood. Arch Dis Child 1954; 29: 502-5.
  12. Choi SI, McClure PD. Idiopathic thrombocytopenic purpura in childhood. Can Med Assoc J 1967; 97: 562-7.
  13. Walker RW, Walker W. ‹diopathic thrombocytopenia, initial illness and long term follow up. Arch Dis Child 1984; 59: 316-22.
  14. Ramos ME, Newman AJ, Gross S. Chronic thrombocytopenia in childhood. Pediatrics 1978; 92: 584-6.
  15. Zaki M, Hassanein AA, Khalil AF. Childhood idiopathic thrombocytopenic purpura. Report of 60 cases from Kuwait. Journal of Tropical Pediatrics 1990; 36: 10-3.
  16. Robb LG, Tiedeman K. Idiopathic thrombocytopenic purpura: predictors of chronic disease. Arch Dis Child 1990; 65: 502-6.
  17. Imbach P, d’Apuzzo V, Hirt A. High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; 1: 1228-31.
  18. Woerner SJ, Abildgaard CF, french BN. Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. Pediatrics 1981; 67: 453-60.
  19. Schattner E, Bussel J. Mortality in immune thrombocytopenic purpura: report of seven case and consideration of prognostic indicators. Am J Hematol 1994; 46:120-6.
  20. Blanchette VS, Luke B, Andrew M, et al. A prospective,randomized trial of high dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993; 123: 989-95.
  21. Belluci S, Charpak Y, Chastang C, Tobelem G. Low doses vs conventional doses of cortic›ids in immune thrombocytopenic purpura (ITP): results of a randomized clinical trial in 160 children, 223 adults. Blood 1988; 71: 1165-9.
  22. Ozsoylu S, Irken G, Karabent A. High dose intravenous methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura. Eur J Haematol 1989; 42: 431.
  23. Saag S, Koehnke R, caldwell JR, et al. Low dose long term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse effects. Am J Med 1994; 96:115-23.
  24. Ozsoylu S, Sayli TR, Ozturk G. Oral megadose methylprednisolone versus intravenous immunglobulin for acute childhood idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 1993; 10:317- 21.
  25. van Hoff J, Ritchey AK. Pulse methylprednisolone therapy acute childhood idiopathic thrombocytopenic purpura. J Pediatr 1988; 113:563- 6.
  26. Albayrak D, Islek I, Kalayc› AG, Gürses N. Acute immune thrombocytopenic purpura: A comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin. J pediatr 1994; 125: 1004- 7.
  27. Blanchette V, Imbach P, Andrew M, et al. Randomized trials of intravenous immunglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994; 344: 703- 7.
  28. Imbach P, Wagner HP, Berchtold W. Intravenous immunglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 1985; 2: 464- 6.
  29. Bussel JB, Goldman A, Imbach P, Schulman I, Hilgartner MW. Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin. J Pediatr 1985; 106: 886- 90.
  30. Bussel JB, Goldman A, Imbach p, Schulman I, Hilgartner MW. Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy. J Pediatr 1983; 103: 651- 4.
  31. Duhem C, Dicato MA, Ries F. Side effects of intravenous immune globulins. Clin Exp Immunol 1994 (suppl 1); 97: 79-83.
  32. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high dose intravenous immunglobulin therapy: Frequency and risk factors. Ann Intern Med 1994; 121: 259–62.
  33. Andrew M, Blancette VS, Adams M, et al. A multicenter study of the treatment of childhood immune thrombocytopenic purpura. with anti-D. J Pediatr 1992; 120:522- 7.
  34. Borgna-Pignatti C, Battisti L, Zecca M, Locatelli F. Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti-D immunglobulins. Br J Haematol 1994; 88: 618- 20.
  35. Zcrella JT, Martin LW, Lampkin BC. Emergency splenectomy for idiopathic thrombocytopenic purpura in children. J Pediatr Surg 1978; 13: 243- 6.
  36. Davis PW, Williams DA, Shamberger RC. Immune thrombocytopenia: Surgical therapy and predictors of response. J Pediatr Surg 1991; 26: 407- 12.
  37. Yang R, Han ZC. Pathogenesis and management of chronic idiopathic thrombocytopenic purpura:An update. Int J Hematol 2000; 71:18- 24.
  38. Najean Y, Rain JD, Billotey A. The site of destruction of autologous 111 In-labeled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies. Br J Haematol 1997; 97: 547–50.
  39. Lortan JE. Clinical annotation. Management of asplenic patients. Br J Haematol 1993; 84: 566-9.
  40. Schilling RF. Estimating the risk for sepsis after splenectomy in hereditary spherocytosis. Ann Intern Med 1995; 122: 187-8.
  41. Hilgartner MW, Lanzkowsky P, Smith CH. The use of azothioprine in refractory idiopathic thrombocytopenic purpura in children. Acta Pediatr Scand 1970; 59: 409-15.
  42. Weinblatt ME, Kochen J, Ortega J. Danazol for children with immune thrombocytopenic purpura. Am J Dis Child 1988; 142: 1317-9.
  43. Cohn RJ, Schwyzer R, Hesseling PB, Poole JE, Naidoo J, Van Herden C. Alpha interferon therapy for severe chronic idiopathic thrombocytopenic purpura in children. Am J Hematol 1993; 43: 246-50.
  44. Verhoef GE, Boonen S, Boogaerts MA. Ascorbate for the treatment of refractory idiopathic thrombocytopenic purpura. Br J Haematol 1990; 74: 234-5.
  45. Imbach P. Immune thrombocytopenic purpura. In: Lilleyman J, Hann I, Blanchette V (eds). Pediatric Hematology 2nd edition. London: Churchill Livingstone; 2000. p.437 – 53.
  46. Blanchette V, Imbach P, Andrew M, et al. Randomized trials of intravenous immunglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994; 344: 703- 7.